These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

293 related items for PubMed ID: 11555443

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Leishmaniasis in Sudan. Visceral leishmaniasis.
    Zijlstra EE, el-Hassan AM.
    Trans R Soc Trop Med Hyg; 2001 Apr; 95 Suppl 1():S27-58. PubMed ID: 11370250
    [Abstract] [Full Text] [Related]

  • 8. Quantifying the Infectiousness of Post-Kala-Azar Dermal Leishmaniasis Toward Sand Flies.
    Mondal D, Bern C, Ghosh D, Rashid M, Molina R, Chowdhury R, Nath R, Ghosh P, Chapman LAC, Alim A, Bilbe G, Alvar J.
    Clin Infect Dis; 2019 Jul 02; 69(2):251-258. PubMed ID: 30357373
    [Abstract] [Full Text] [Related]

  • 9. Visceral leishmaniasis in eastern Sudan: parasite identification in humans and dogs; host-parasite relationships.
    Dereure J, El-Safi SH, Bucheton B, Boni M, Kheir MM, Davoust B, Pratlong F, Feugier E, Lambert M, Dessein A, Dedet JP.
    Microbes Infect; 2003 Oct 02; 5(12):1103-8. PubMed ID: 14554251
    [Abstract] [Full Text] [Related]

  • 10. Post-kala-azar dermal leishmaniasis--an overview.
    Ganguly S, Das NK, Barbhuiya JN, Chatterjee M.
    Int J Dermatol; 2010 Aug 02; 49(8):921-31. PubMed ID: 21128917
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Detection of asymptomatic Leishmania infection in Bangladesh by antibody and antigen diagnostic tools shows an association with post-kala-azar dermal leishmaniasis (PKDL) patients.
    Owen SI, Hossain F, Ghosh P, Chowdhury R, Hossain MS, Jewell C, Cruz I, Picado A, Mondal D, Adams ER.
    Parasit Vectors; 2021 Feb 17; 14(1):111. PubMed ID: 33597000
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. IL-10- and TGF-beta-mediated susceptibility in kala-azar and post-kala-azar dermal leishmaniasis: the significance of amphotericin B in the control of Leishmania donovani infection in India.
    Saha S, Mondal S, Ravindran R, Bhowmick S, Modak D, Mallick S, Rahman M, Kar S, Goswami R, Guha SK, Pramanik N, Saha B, Ali N.
    J Immunol; 2007 Oct 15; 179(8):5592-603. PubMed ID: 17911647
    [Abstract] [Full Text] [Related]

  • 17. Post-kala-azar dermal leishmaniasis.
    Zijlstra EE, Musa AM, Khalil EA, el-Hassan IM, el-Hassan AM.
    Lancet Infect Dis; 2003 Feb 15; 3(2):87-98. PubMed ID: 12560194
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Leishmania promastigote membrane antigen-based enzyme-linked immunosorbent assay and immunoblotting for differential diagnosis of Indian post-kala-azar dermal leishmaniasis.
    Saha S, Mazumdar T, Anam K, Ravindran R, Bairagi B, Saha B, Goswami R, Pramanik N, Guha SK, Kar S, Banerjee D, Ali N.
    J Clin Microbiol; 2005 Mar 15; 43(3):1269-77. PubMed ID: 15750095
    [Abstract] [Full Text] [Related]

  • 20. Using focused pharmacovigilance for ensuring patient safety against antileishmanial drugs in Bangladesh's National Kala-azar Elimination Programme.
    Hossain MS, Kumar A, Hossain AFMA, Mahshin M, Sharma A, Hossain MA, Sharma V, Haque R, Shamsuzzaman AKM, Maruf S, Ghosh P, Ahuja V, Mondal D.
    Infect Dis Poverty; 2018 Aug 13; 7(1):80. PubMed ID: 30099967
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.